Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 212

The DOI matches its Crossref record.

Renal Parenchymal Hypoxia, Hypoxia Response and the Progression of Chronic Kidney Disease

Open access
Heyman, Samuel N., Khamaisi, Mogher, Rosen, Seymour, Rosenberger, Christian·2008·American Journal of Nephrology

Abstract

Kidney function, determined as the glomerular filtration rate (GFR), declines at a rate of about 1 ml/min per year. In patients with chronic kidney disease (CKD), the rate of decline in GFR is accelerated and may reach over 10 ml/min per year.In the 1980s, Brenner et al. [1, 2] suggested that altered glomerular hemodynamics govern the accelerated progression of chronic renal failure (CRF). They assumed that an initial reduction in renal cell mass leads to a ‘wear and tear’ phenomenon, with glomerular hypertension, hyperfiltration, and hypertrophy of functioning glomeruli, ultimately ending with glomerular sclerosis, glomerular dropout, and the generation of an ongoing vicious circle of progressive renal damage.The major flaw in this hypothesis is that in patients with chronic renal disease the extent of renal dysfunction poorly associates with changes in glomerular morphology, whereas it correlates well with chronic tubulointerstitial injury [3]. This has shifted the interest to multiple other factors, including proteinuria and associated interstitial cytokine release, in the progression of CKD [4]. Numerous studies have underlined the importance of oxygen free radicals, vasoactive substances, tubular hypertrophy, hypermetabolism, and endothelial dysfunction, but noteworthy, until 1998 the word ‘hypoxia’ was still missing in graphic illustrations of this complex pathophysiology [5].In 2000, Fine et al. [6] pointed out that inhibitors of the renin-angiotensin-aldosterone axis slow the progression of CRF regardless of the control of hypertension or the presence or absence of proteinuria. Their review forms the basis for a new evolving concept on the role of hypoxia in the progression of CKD. They proposed that kidney injury leads to a vicious circle of tissue fibrosis, pursuant obliteration of the renal microvasculature, hypoxia and continued damage [6].Indeed, renal parenchymal hypoxia has been consistently documented by currently available technologies. Regional renal microcirculation and PO2 can be continuously monitored under experimental settings with needle-laser Doppler flow probes and with oxygen microelectrodes, respectively. The distribution of renal parenchymal hypoxia and hypoxia adaptive responses can now be mapped using immunostaining for pimonidazole (molecular ‘hypoxia probe’ which, following injection, binds to tissues with oxygen tension below 10 mm Hg) and for hypoxia-inducible factors (HIF; see below). Finally, blood oxygenation level-dependent (BOLD) MRI provides a noninvasive measure to determine the dynamic changes in the distribution and extent of deoxygenated hemoglobin within the renal parenchyma. Based on these technologies, we shall appraise the evidence for renal parenchymal hypoxia under conditions that predispose to accelerated progression of CKD, providing insight into potential interventional measures in efforts to retard the decline in kidney function.Renal parenchymal oxygenation reflects the balance between regional oxygen supply and oxygen consumption, principally for tubular transport [7, 8]. Oxygen demand is governed by GFR, by tubular and ion-pump mass, and by various regulators that control transport activity. Oxygen supply mirrors systemic and intrarenal factors that control intrarenal blood flow and distribution, the oxygen-carrying capacity of the blood, and the specific structure of the renal microcirculation. Peritubular capillaries are nourished by efferent glomerular arterioles. Efferent arteriolar PO2 is lower than renal venous PO2, implying cortical precapillary shunting that leads to renal parenchymal hypoxia [9]. Furthermore, a non-homogenous distribution of renal parenchymal oxygenation exists, with renal parenchymal pO2 sharply declining at the cortico-medullary junction, reaching levels as low as 25 mm Hg within the renal medulla under normal physiologic conditions [7, 10]. This physiologic hypoxia of the renal medulla stems from limited oxygen supply, barely sufficient for ample regional oxygen consumption (fig. 1). The medulla receives some 10%, only, of total renal blood flow originating from efferent arterioles of deep juxtamedullary glomeruli. These blood vessels merge to form vascular bundles (vasa recta), a central component of the renal concentrating machinery. Importantly, the unique architecture of a countercurrent blood flow in vasa recta facilitates oxygen diffusion from descending to ascending blood vessels and contributes to reduced oxygen availability to the medulla. At the same time, the outer medullary oxygen requirement for tubular transport by medullary thick ascending limbs (mTALs) and S3 (straight) segments of the proximal tubules is intense. Complex mechanisms participate in the preservation of renal medullary oxygen sufficiency, by the control and matching of both intrarenal blood flow and tubular transport activity (fig. 2). Prostaglandins (principally PGE2), nitric oxide, adenosine and other mediators act in concert to maintain th

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000146075

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 212

Metadata

Authors
Heyman, S. N., Khamaisi, M., Rosen, S., & Rosenberger, C.
Venue
American Journal of Nephrology
Publisher
S. Karger AG
Published
2008
Volume
28
Issue
6
Pages
998-1006
ISSN
  • 0250-8095 (ISSN-L)
  • 1421-9670
OpenAlex
W2000158535
Cited by
212
References
0
FWCI
10.80
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Renal Parenchymal Hypoxia, Hypoxia Response and the Progression of Chronic Kidney Disease. https://app.cochat.ai/papers/10.1159/000146075
The paper
Heyman, S. N., Khamaisi, M., Rosen, S., & Rosenberger, C. (2008). Renal Parenchymal Hypoxia, Hypoxia Response and the Progression of Chronic Kidney Disease. American Journal of Nephrology. https://doi.org/10.1159/000146075

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.